Harvard Business Review

SEPTEMBER 14, 2017

The belief is that at-risk pay motivates salespeople to work hard and direct effort towards sales activities that encourage achievement of sales goals. a high second number) motivates salespeople to drive short-term results. In the short term, however, these sales are free to the salesperson.

Motivation 8

Motivation Incentives Franchising Short-term 8

Harvard Business Review

SEPTEMBER 13, 2011

You either achieve your goals or you don't. But only athletic events produce clear winners and losers in the short-term — and most organizations are not actively engaged in those. Rather, we need to better understand how these numbers were achieved and what they are actually saying about a company's long-term health.

Short-term 13

Short-term Pharmaceuticals Long-term Maturity 13

Harvard Business Review

OCTOBER 24, 2017

These have forced AirBnB, Tesla, and Uber to make costly concessions to their operating practices or to exit certain markets altogether. Lobbying for policy reform isn’t much of an answer, because incumbents generally have the benefit of long-term relationships with government agencies built up over many years. In the U.S.,

Licensing 9

Licensing Proposal Retail Long-term 9

Harvard Business Review

MAY 1, 2013

While currently crippled by inadequate infrastructure in many countries, low- and middle-income countries will be the fastest-growing markets for pharmaceuticals and medical devices over the next decade. What can the health care industry do to help fight disease, while still maintaining its commitments to shareholders? Redefine ROI.

Health Care 8

Health Care ROI NGO Long-term 8

Harvard Business Review

MAY 24, 2012

Pharmaceutical manufacturers, insurers, and retailers invest millions in risk avoidance. Every business day, companies cede hard evidence to the political agendas of a willful manager or department, and these companies span geographies, industries, revenues, and market segments. Risk management isn't exclusive to banking.

Merchandising 10

Merchandising Risk Management Supply Chain Retail 10

Harvard Business Review

JUNE 29, 2015

Second, the main goal of PE investors is to increase a firm’s value so that it can be sold for profit. At the same time, there are certain ways LBOs can actually make it easier for firms to invest in the long term. There’s a longstanding debate about whether private equity investors create value for the firms they buy.

LBO 8

LBO Innovation Sample Short-term 8

Harvard Business Review

SEPTEMBER 5, 2016

Cigna is the first insurance company to get pharmaceutical companies to agree to value pricing based on results for certain cholesterol-lowering drugs. Another problem we’ve seen is that some providers, seeking to fit in to a payment cycle, focus on short-term results, losing sight of the end goals.

Incentives 8

Incentives Health Care Education Insurance 8

Harvard Business Review

SEPTEMBER 10, 2013

A good idea faces so many obstacles en route to market today that it''s a wonder we have any innovative products at all. That''s why it''s important that venture funds'' goals be aligned with corporate objectives, approvals for funding be streamlined, and compensation levels match those offered by independent venture groups.

Venture Capitalist 8

Venture Capitalist Venture Funding Innovation Incentives 8

Harvard Business Review

SEPTEMBER 10, 2013

A good idea faces so many obstacles en route to market today that it’s a wonder we have any innovative products at all. It’s important to have a specific goal at the outset, and the rewards should be meaningful, but they don’t always have to involve cash. It’s like that. Recognition is a powerful reward too.

Venture Capitalist 8

Venture Capitalist Venture Funding Innovation Incentives 8

Harvard Business Review

DECEMBER 27, 2013

Sure, the company was eventually both punished and sold (it’s now one of the fastest-growing pharmaceutical businesses in the U.S.). In it, he traces the intersection of science and marketing that''s made junk food so delicious, so profitable, and so very bad for you. But is it actually working?

Armstrong 8

Armstrong Long-term Short-term CEO 8

Harvard Business Review

OCTOBER 8, 2013

Today, payers and providers are using a range of strategies to accomplish this goal, including patient-centered medical homes , value-based contracting , and accountable care organizations (ACOs). In short, REBP can serve as a bridge to more comprehensive total-cost-of-care approaches. We applaud this trend. How Does REPB Work?

Health Care 8

Health Care Cost Analysis Competitive Advantage 8

Harvard Business Review

MAY 12, 2011

Instead of a pharmaceutical industry, I see a new set of mental and physical discontents, like rates of suspiciously normally "abnormal" mental illnesses and drugs whose lists of "side effects" are longer than the Magna Carta. I see, instead of food and education "industries," an obesity epidemic and a debt-driven education crisis.

GDP 21

GDP Hamel Industry Construction 21

Harvard Business Review

JUNE 12, 2018

The pervasive adoption of mobile devices has driven an explosion of contextual user information, including geolocation data, which has become a valuable resource for marketers. However, a lack of technical skill sets among marketers has made it difficult for them to use this data (when they have access to it) effectively.

Short-term 8

Short-term Brand Long-term Media 8

Harvard Business Review

NOVEMBER 3, 2017

However, beyond the strategic goal of becoming an industry leader in terms of cost structure, there was no “story” for how this effort would complement the business’s broader ambitions. The team tasked with overseeing the effort designed an aggressive implementation plan that tied targets to manager compensation.

Execution 14

Execution Strategy Decentralization Short-term 14

Harvard Business Review

JULY 20, 2017

This is the challenge for all kinds of disruptors, whether in the auto industry, pharmaceuticals, service industries, or healthcare. DNA genetic testing company 23andMe fell behind on its communications with the FDA, resulting in a temporary ban on marketing the company’s personal genetic screening services to the public.

Innovation 13

Innovation Productivity Products Venture Capitalist 13